NASDAQ:MAZE | News | Maze Therapeutics, Inc.

MAZE News

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2026-08-17Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01.
2026-08-11Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-06-10Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 5.07.
2026-05-22Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 5.02.
2026-05-12Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2026-04-22Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2026-03-25Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 2.02,5.02,7.01,9.01.
2026-02-04Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 1.01,1.02,2.03.
2025-11-06Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-10-06Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 5.02.
2025-09-11Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01.
2025-09-02Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 5.02.
2025-08-12Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-05-14Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2025-03-31Current reportSEC filingMaze Therapeutics, Inc. filed Form 8-KMaze Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.